SI2566472T1 - Farmacevtski sestavek, ki obsega Aspirin in bisoprolol - Google Patents

Farmacevtski sestavek, ki obsega Aspirin in bisoprolol

Info

Publication number
SI2566472T1
SI2566472T1 SI201130407T SI201130407T SI2566472T1 SI 2566472 T1 SI2566472 T1 SI 2566472T1 SI 201130407 T SI201130407 T SI 201130407T SI 201130407 T SI201130407 T SI 201130407T SI 2566472 T1 SI2566472 T1 SI 2566472T1
Authority
SI
Slovenia
Prior art keywords
bisoprolol
aspirin
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
SI201130407T
Other languages
English (en)
Inventor
Ann Donegan
Stephen Paul Closs
Danashankar Mallappa
Original Assignee
Cal International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cal International Limited filed Critical Cal International Limited
Publication of SI2566472T1 publication Critical patent/SI2566472T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI201130407T 2010-05-06 2011-05-05 Farmacevtski sestavek, ki obsega Aspirin in bisoprolol SI2566472T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33191610P 2010-05-06 2010-05-06
EP11720589.8A EP2566472B1 (en) 2010-05-06 2011-05-05 A pharmaceutical composition comprising aspirin and bisoprolol
PCT/IE2011/000027 WO2011138772A1 (en) 2010-05-06 2011-05-05 A pharmaceutical composition comprising aspirin and bisoprolol

Publications (1)

Publication Number Publication Date
SI2566472T1 true SI2566472T1 (sl) 2015-04-30

Family

ID=44246384

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201130407T SI2566472T1 (sl) 2010-05-06 2011-05-05 Farmacevtski sestavek, ki obsega Aspirin in bisoprolol
SI201130911A SI2857014T1 (sl) 2010-05-06 2011-05-05 Farmacevtski sestavek, ki vsebuje aspirin ter bisoprolol

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI201130911A SI2857014T1 (sl) 2010-05-06 2011-05-05 Farmacevtski sestavek, ki vsebuje aspirin ter bisoprolol

Country Status (11)

Country Link
EP (2) EP2566472B1 (sl)
EA (2) EA201691986A1 (sl)
ES (2) ES2528119T3 (sl)
HR (2) HRP20150125T1 (sl)
HU (1) HUE029647T2 (sl)
PL (2) PL2566472T3 (sl)
PT (1) PT2566472E (sl)
RS (2) RS55064B1 (sl)
SI (2) SI2566472T1 (sl)
UA (1) UA109895C2 (sl)
WO (1) WO2011138772A1 (sl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3027803B1 (fr) 2014-11-05 2018-02-09 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2120878T3 (pl) * 2007-02-09 2015-01-30 Alphapharm Pty Ltd Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych

Also Published As

Publication number Publication date
ES2528119T3 (es) 2015-02-04
EP2857014B1 (en) 2016-06-22
EP2566472B1 (en) 2015-01-07
HRP20161153T1 (hr) 2016-11-18
SI2857014T1 (sl) 2016-09-30
EA201691986A1 (ru) 2017-03-31
ES2581158T3 (es) 2016-09-01
EA201290776A1 (ru) 2013-04-30
EA026163B1 (ru) 2017-03-31
PL2566472T3 (pl) 2015-06-30
HRP20150125T1 (hr) 2015-03-27
RS53846B1 (en) 2015-08-31
RS55064B1 (sr) 2016-12-30
UA109895C2 (uk) 2015-10-26
PT2566472E (pt) 2015-03-04
PL2857014T3 (pl) 2016-12-30
EP2566472A1 (en) 2013-03-13
WO2011138772A1 (en) 2011-11-10
EP2857014A1 (en) 2015-04-08
HUE029647T2 (en) 2017-03-28

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
HK1253692A1 (zh) 含有hdac抑制劑和環多醣的藥物組合物
ZA201304709B (en) A pharmaceutical dosage form
EP2642983A4 (en) DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT
IL247079A0 (en) A rapidly dissolving pharmaceutical compound
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
HK1205456A1 (en) A solid oral pharmaceutical formulation containing ticagrelor
ZA201304633B (en) A pharmaceutical composition
GB2486567B (en) Pharmaceutical formulation
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
HK1152485A1 (en) A pharmaceutical composition comprising l-carnitine and dobesilate
HK1181649A1 (en) A fast dissolving pharmaceutical composition
PT2597084T (pt) Derivado de n-hidroxiformamida e medicamento contendo o mesmo
HRP20141173T1 (hr) Medikament koji sadrži miramistin
HRP20150125T1 (hr) Farmaceutski oblik koji sadrži aspirin i bisoprolol
ZA201201003B (en) A pharmaceutical composition
PL2651390T3 (pl) Orodyspersyjna tabletka farmaceutyczna na bazie zolpidemu
IL227250A (en) Pain-relieving compounds and pharmaceuticals containing them
GB201002451D0 (en) Pharmaceutical comopitions and devices
ZA201201424B (en) Pharmaceutical dosage form
EP2641603A4 (en) PHARMACEUTICAL FORMULATION HAVING NEUROPROTECTIVE ACTIVITY
GB201018615D0 (en) Novel compounds and use thereof as a medicament
GB201018773D0 (en) Topical pharmaceutical formulation